Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Highly expressed RPLP2 inhibits ferroptosis to promote hepatocellular carcinoma progression and predicts poor prognosis

Fig. 7

The nomogram with RPLP2 shows excellent performance in the diagnosis and prognosis of HCC. A ROC analysis of RPLP2 in HCC. B–H Diagnostic value of RPLP2 mRNA level in different HCC subgroups including, G3 and G4 (B), T1 and T2 (C), T3 and T4 (D), N0 (E), M0 (F), Stage I and II (G) and Stage III and IV (H). I Time-dependent survival ROC analysis for predicting the probability of HCC patients with 1-, 3- and 5-year survival. J Nomogram for predicting the 1-, 3- and 5-year overall survival rates of HCC patients. (The data was obtained from TCGA-LIHC)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us